Education
About Us
Working with TipRanks
Follow Us
Jeremy P. Springhorn Insider Profile
11 Followers
Jeremy P. Springhorn, Director at uniQure, holds 37.69K shares in uniQure (Ticker: QURE), holds 35.00K shares in Syros Pharmaceuticals (Ticker: SYRS). Most recently, Jeremy P. Springhorn Sold ― shares of uniQure on Jun 24, 2025 for an estimated value of $30.52K.
Profitable Transactions
4 out of 9 Profitable Transactions
Average Return
-10.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeremy P. Springhorn holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jeremy P. Springhorn
Jeremy P. Springhorn's Trading History
uniQure
Jun 24, 2025
Director
Informative Sell
30.52K
$606.50K
Syros Pharmaceuticals
Nov 12, 2019
CBO
Uninformative Buy
99.50K
$665.00
List of latest transactions for each holding click on a transaction to see Jeremy P. Springhorn's performance on stock
You May Also Like
Jeremy P. Springhorn insider profile FAQ
What is the percentage of profitable transactions made by Jeremy P. Springhorn?
The percentage of profitable transactions made by Jeremy P. Springhorn is 44%.
What is the average return per transaction made by Jeremy P. Springhorn?
The average return per transaction made by Jeremy P. Springhorn is -10.30%.
What stocks does Jeremy P. Springhorn hold?
Jeremy P. Springhorn holds: QURE, SYRS stocks.
What was Jeremy P. Springhorn’s latest transaction?
Jeremy P. Springhorn latest transaction was an Informative Sell of $30.52K.
What was Jeremy P. Springhorn's most profitable transaction?
Jeremy P. Springhorn’s most profitable transaction was an Informative Sell of QURE stock on June 20, 2023. The return on the trade was 76.50%.
What is Jeremy P. Springhorn's role in uniQure?
Jeremy P. Springhorn's role in uniQure is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.